Skip to main content

Table 3 Clinical evolution

From: Effects on muscle performance of NSAID treatment with Piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. a double blind randomized controlled trial

  

Placebo

Piroxicam

p

Clinical evolution (number of patients)

    
 

Return to premorbid

clinical status

6

10

0.127*

 

Persistent decrease in

clinical status

8

4

 

Side effects (attributable to NSAID)

    
 

None

13

8

0.075*

 

Possible

1

3

 
 

Probable

0

3

 

Length of stay (days; median, range)

 

24.5 (19-64)

29.0 (9-75)

0.836†

Death

 

1

2

0.541*

  1. *Pearson Chi square test. †Mann Whitney U test.